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In addition to RDH5, other enzymes capable of oxidizing 11-cis-retinol are present within the retinal pigment epithelium, M€uller
cells and/or photoreceptors. Candidate proteins have meanwhile been identiﬁed. To study the physiological and pathological aspects
of these enzymes, mice in which these genes are no longer functional are being generated. A fast-targeting strategy for the disruption
of genes was developed. Generation of double and triple knockouts will aid in determining if these retinol dehydrogenases are
responsible for the remaining 11-cis-retinol oxidation observed in RDH5 knockout animals.
 2003 Elsevier Ltd. All rights reserved.
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Vision is triggered by visual pigments consisting of a
protein moiety called opsin and the vitamin A-derivative
11-cis-retinal (for a review see McBee, Palczewski,
Baehr, & Pepperberg, 2001). Phototransduction is ini-
tiated by capture of a photon and subsequent isomer-
ization of 11-cis-retinal to all-trans-retinal. Following
bleaching, the all-trans-retinal chromophore is released
from the protein. Visual pigment regeneration requires
that all-trans-retinal is converted back into 11-cis-reti-
nal. In this process diﬀerent enzymatic conversions of
retinoids are needed and a number of the enzymes in-
volved have been identiﬁed. In the best-characterized
pathway, all-trans-retinal is reduced to all-trans-retinol
by all-trans-retinol dehydrogenase(s) present in photo-
receptor cells (Haeseleer & Palczewski, 2000; Rattner,
Smallwood, & Nathans, 2000). All-trans-retinol is* Corresponding author. Tel.: +31-2-43614451; fax: +31-2-
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doi:10.1016/S0042-6989(03)00483-8transported to the retinal pigment epithelium (RPE) and
isomerized into 11-cis-retinol. Finally 11-cis-retinol is
oxidized to 11-cis-retinal through the action of 11-cis-
retinol dehydrogenases and transported back to the
photoreceptor cells (Driessen et al., 1995; Simon, Hell-
man, Wernstedt, & Eriksson, 1995).
Recently a retinoid cycle speciﬁc for cone pigment
regeneration was described (Mata, Radu, Clemmons, &
Travis, 2002; Wood, 2002). It has been suggested that
this second pathway involves an interplay between
M€uller cells and cone photoreceptors. First all-trans-
retinal is reduced to all-trans-retinol in the cones. Sub-
sequently all-trans-retinol is transported to the M€uller
cells and isomerized into 11-cis-retinol, which is then
transported back to the cones and oxidized to 11-cis-
retinal.
A third possible mechanism of 11-cis-retinal forma-
tion is the direct isomerization of all-trans-retinal into
11-cis-retinal by a retinal G-protein-coupled receptor
(RGR), a retinochrome present in both M€uller cells and
RPE (Wolf, 2002). In vitro RGRwas demonstrated to be
capable of photoisomerase activity (Hao & Fong, 1999).
So far only a limited number of players in the path-
ways mentioned above are known. One of these is
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active in the ﬁrst pathway. Mice were developed carry-
ing a targeted deletion of this gene and it was shown that
these mice are still capable of regenerating their rod
visual pigment in the dark (Driessen et al., 2000; Shang
et al., 2002). Hence, in addition to RDH5, other en-
zymes capable of oxidizing 11-cis-retinol need to be
present within the RPE, M€uller cells and/or photore-
ceptors. The residual retinol dehydrogenase enzyme
activity in the retina was characterized (Jang et al.,
2001). The characteristics concerning substrate speciﬁc-
ity and cofactor usage of these enzymes were determined.
Several candidate genes were identiﬁed (Haeseleer et al.,
2002). The encoded proteins all display the correct
biochemical characteristics and have unique expression
patterns within the retina. The most interesting amongst
these are RDH11, RDH12 and RDH15 (unpublished
data). These three oxidoreductases display high levels of
expression in speciﬁc retinal cell types, use NADP(H) as
a cofactor and are capable of oxidizing both 11-cis-ret-
inol and all-trans-retinol.
RDH5 knockout mice provided important informa-
tion regarding the involvement of RDH5 in the retinoid
cycle. To determine the relative contribution of RDH12
and RDH15 in the regeneration pathways of visual
pigments, we aim to generate mice with a targeted de-
letion of both genes. In our targeting strategy 50 and 30
arms of the targeted genes were obtained by genomic
PCR and cloned in a basic targeting vector, thereby
eliminating the time consuming steps of screening mouse
genomic DNA libraries and further characterization of
isolated genomic clones. This elegant strategy will be
useful for generation of mice carrying a targeted dele-
tion in an arbitrary gene, since nowadays data from the
mouse genome are available via databases and can be
used to construct targeting vectors for gene inactivation.2. Materials and methods
2.1. Construction of the basic targeting vector
In the pgem13zf(+) vector (Promega) a multiple
cloning site was introduced using the phosphorylated
oligomers MCS01 50-ggccgctagcgaattcgtcgacggtaccg-
gatcca-30 and MCS02 50-agcttggatccggtaccgtcgacgaattc-
gctagc-30. This leads to the introduction of unique
recognition sites into the pgem13zf(+) vector for the
following restriction enzymes (from 50 to 30, respec-
tively): Not I, Nhe I, EcoR I, Sal I, Kpn I, BamH I and
Hind III.
The herpes simplex virus thymidine kinase (HSVtk)
cassette was cloned in the sense direction as a BamH I
fragment. Subsequently the neomycin cassette was iso-
lated as a Xho I fragment from Pha178pMC1neo
(Stratagene) and cloned in the sense direction using theSal I restriction site. Hence, the 50 fragment of the tar-
geted gene can either be cloned unidirectionally as a Nhe
I/EcoR I fragment or random as a Nhe I or a EcoR I
fragment. The 30 fragment of the targeted gene can only
be cloned as a Kpn I fragment. Finally the targeting
vector can be linearized with either Not I or Hind III.2.2. Construction of the RDH15 targeting vector
The 50 and 30 fragments of the RDH15 gene were
obtained by long range PCR on genomic DNA isolated
from 129/Sv mouse embryonic stem cells (ES). Primers
used for ampliﬁcation of the 2400 bp 50 fragment of
RDH15 were 50-cccgctagctcctccagtggttgtaaggacaggattt-
30 and 50-ggggctagcattatgtagccctggctgctgaaactttct-30
(underlined are Nhe I restriction sites) and for the 2500
bp 30 fragment of RDH15 50-cccggtacccttttgagcactttaa-
aatatttccactt-30 and 50-gggggtacccaagctacctgctttcattaaa-
cggagaag-30 (underlined are Kpn I restriction sites).
Cycling conditions: 1 min 94 C, 40 cycles 45 s 94 C, 7
min 65 C, and ﬁnally 10 min 72 C, using rTth DNA
polymerase XL (PerkinElmer Life Sciences). Both
fragments were cloned in the PCRII Topo vector (In-
vitrogen) and isolated as a Nhe I or Kpn I fragment and
subsequently cloned in the basic targeting vector.2.3. RDH15 screening for homologous recombination
After electroporation of the Not I linearized RDH15
targeting vector, ES cells (129/Sv) were cultured on se-
lective medium containing 350 lg of neomycin (G418)
per ml and 0.2 lM FIAU. Appropriate targeting of the
RDH15 gene was initially checked with PCR using ge-
nomic DNA isolated from ES cells cultured on gelatin
coated 96 wells plates. Homologous recombination on
the 50 end was checked using the primer combination 50-
ttgtttagagaggaggttacatgggaagtg-30 and 50-gccccgactg-
catctgcgtgtt-30, resulting in a 2757 bp fragment. For the
30 end we used the primer combination 50-ctttacgg-
tatcgccgctcc-30 and 50-tggttgaagatgaagaacctggagctcaag-
30, resulting in a 2793 bp fragment. Cycling conditions: 1
min 94 C, 40 cycles 45 s 94 C, 7 min 65 C, and ﬁnally
10 min 72 C, using rTth DNA polymerase XL (Perk-
inElmer Life Sciences).
To verify the ES cell lines selected with PCR, ap-
propriate targeting was also checked with Southern blot
analysis. For ampliﬁcation of the 50 probe the following
primer combination was used 50-gagccaaggaatgggcactc-
tttagcaaa-30 and 50-ccctggtgataaggaacagagagggacttt-30
and for the 30 probe 50-tccacagctgtttctgtcctgccattcat-
30 and 50-gaccctgcatctatgcccaaactcactttt-30, resulting in
551 and 548 bp fragments, respectively. The 50 probe
detected a 4.6 kb BamH I fragment derived from the
targeted allele and a 3.4 kb BamH I fragment from the
wild-type allele, and the 30 probe a 3.1 and 6.4 kb BamH
C. Driessen et al. / Vision Research 43 (2003) 3075–3079 3077I fragment from the targeted and wild-type alleles, re-
spectively.3. Results
3.1. Construction of the targeting vector
The entire murine RDH15 gene is present in clone
NT_039208.1, originating from mouse chromosome 2.
The positions of four exons were determined using the
sequence of the murine RDH15 cDNA (Fig. 1). How-
ever, as with RDH5, the presence of a non-coding exon
positioned upstream of the ﬁrst coding exon cannot be
excluded. The RDH5 gene from several species is com-
posed of ﬁve exons of which the ﬁrst exon is entirely
non-coding (Driessen et al., 1998; Romert, Tuvendal,
Tryggvason, Dencker, & Eriksson, 2000; Simon, Lag-
ercrantz, Bajalica-Lagercrantz, & Eriksson, 1996).
The strategy for targeted disruption of the RDH15
gene requires the ampliﬁcation of the 50 and 30 arms
using genomic DNA isolated from mouse 129/Sv ES
cells. Using the murine RDH15 genomic sequence, we
designed primer sets in order to amplify the 50 and 30
arms. The primers for amplifying the 50 arm was ex-
tended with Nhe I recognition sites, and primers for the
30 arm with Kpn I. The size of the obtained PCR
products were in good agreement with the predicted
sizes (data not shown). PCR products were cloned in the
PCRII Topo vector and partially sequenced to conﬁrm
that the correct genomic regions of the murine RDH15
gene were ampliﬁed and cloned. The 50 and 30 arms wereFig. 1. Targeted disruption of the RDH15 gene. Schematic represen-
tation of the basic targeting vector, RDH15 targeting vector, organi-
zation of the wild-type and targeted RDH15 alleles. Not shown is the
position of exon 4 (intron 3 is about 3.5 kb). Homologous recombi-
nation results in the replacement of exons 1 (containing the atg start
codon) and 2 by a neomycin cassette (Neo). Filled boxes denote exon
positions, dashed boxes denote positions of the 50 and 30 probe. The
positions of the primers used for identiﬁcation of targeted ES cell lines
are marked by an asterisk.rescued from the plasmids using Nhe I or Kpn I, re-
spectively, and subcloned into the basic targeting vector,
already containing the positive selection marker neo-
mycin and the negative selection marker herpes simplex
virus thymidine kinase (HSVtk).3.2. Transfection to ES cells
The targeting construct was linearized with Not I and
transfected to ES cells. Transfected ES cells were plated
on dishes with irradiated Snl cells necessary for LIF
production. After exposing the ES cells to G418 for 5–7
days, 211 clones were selected. All clones were checked
for homologous recombination.
In an attempt to reduce experimental time for cloning
and identiﬁcation of the correct targeted ES cell lines, we
decided to develop a PCR protocol to check for correct
homologous recombination in RDH15 targeted ES cell
lines (Fig. 2, panel A). We therefore cultured all 211
selected cell lines on gelatin-coated 96 wells plates and
subsequently isolated genomic DNA. Two primer
combinations were designed. A sense primer in the
neomycin cassette in combination with an antisense
primer downstream of the 30 arm was used to screen for
correct recombination of the 30 arm. Four cell lines
showed the presence of a 2793 bp ampliﬁed PCR
product. These cell lines were subsequently used to
check for correct recombination of the 50 arm using a
sense primer upstream of the 50 arm and an antisense
primer in the neomycin cassette. Cell lines 1A5 and
3A12 showed the presence of a 2757 bp PCR product.
Unfortunately, we were not able to amplify the
complete targeted gene using the primers upstream of
the 50 arm and downstream of the 30 arm. We thereforeFig. 2. Identiﬁcation of RDH15 targeted cell lines using PCR (panel
A) and Southern blot analysis (panels B and C). (A) For PCR analysis
genomic DNA from G418-resistant ES cell lines was analysed with two
primer combinations for checking the 50 and 30 integration events,
respectively. Two positive cell lines, 1A5 and 3A12, are shown. (B)
Southern blot analysis with the 50 ﬂanking probe of genomic DNA of
cell lines 1A5 and 3A12 and wild-type 129/Sv genomic DNA digested
with BamH I. A targeted allele is identiﬁed by a 4.6 kb fragment in
addition to a 3.4 kb wild-type allele. (C) The 30 ﬂanking probe iden-
tiﬁed a 3.1 kb fragment for the targeted allele and a 6.4 kb fragment for
the wild-type allele.
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homologous recombination also by Southern blot
analysis (Fig. 2, panels B and C). Southern blot analysis
was performed using BamH I digested genomic DNA.
Based on the sequence data from the mouse genome
database we predicted a 3.4 kb fragment of the wild-type
gene and a 4.6 fragment of the targeted gene upon
screening the blot with the 50 probe located upstream of
the 50 arm. The detected bands both perfectly matched
the predicted size. For the 30 probe we predicted a 6.4
and 3.1 kb fragment for the wild-type and targeted gene,
respectively. The detected bands also matched those
predicted sizes. These results indicated that in cell lines
1A5 and 3A12 exons 1 and 2 are replaced by a neomycin
cassette, thereby conﬁrming the results obtained by
PCR. Both cell lines were used for blastocyst injection.
Among the oﬀspring, seven chimeric males (20–60%
Agouti coat color) and seven chimeric females (20–60%
Agouti coat color) were identiﬁed.4. Discussion
This report describes a targeting strategy for gener-
ation of RDH15 knockout mice. This strategy will be
employed also for the construction of mice with a tar-
geted deletion of the RDH12 gene. Both oxidoreducta-
ses are thought to be candidates for playing an
important role in the retinal retinoid cycle. High levels
of RDH15 transcription were detected in both retina
and RPE using Northern blot analysis (F. Haeseleer,
unpublished data). RT-PCR using RDH15-speciﬁc
primers, located in a region not conserved between ret-
inol dehydrogenases, showed the presence of human
RDH15 transcripts not only in retina and RPE but also
in heart, pancreas, prostate, liver, lung, kidney and testis
(J. Janssen, unpublished data). The encoding region of
the mouse RDH15 transcript shows 93% identity to a
retinol dehydrogenase homolog (Rdhl) cyclically ex-
pressed in the uterine epithelium of rat (Rexer & Ong,
2002). Cotransfection of RdhI and rat aldehyde dehy-
drogenase RALDH3 in COS cells resulted in the pro-
duction of retinoic acid from retinol provided in culture.
Furthermore 84% homology is found with a cDNA
clone from a library of human tracheobronchial epi-
thelial cells which was isolated as a retinoic acid
responsive clone upon diﬀerential hybridization screen-
ing (Soref et al., 2001). This group provided evidence
that the recombinant protein is able to metabolize all-
trans-retinol. An identical cDNA clone was isolated by
Chetyrkin and coworkers as a human microsomal 3a-
hydroxysteroid dehydrogenase (Chetyrkin, Belyaeva,
Gough, & Kedishvili, 2001).
Previously, RDH12 transcripts were detected in the
inner segments of photoreceptors in monkey retinae
using digoxigenin labelled antisense probes (Haeseleeret al., 2002). Recombinant RDH12 was found to be able
to catalyze the reduction of both all-trans-retinal and
cis-retinals with high eﬃciency.
Another candidate enzyme to play a role in the retinal
retinoid metabolism is RDH11 (Haeseleer et al., 2002),
originally cloned as a prostate short-chain dehydrogen-
ase/reductase PSDR1 (Kedishvili et al., 2002; Lin et al.,
2001; Moore, Pritchard, Lin, Ferguson, & Nelson,
2002). A high level of RDH11 expression was detected
in the RPE and a lower level in the M€uller cells. Im-
munoprecipitation experiments suggested that RDH5
and RDH11 may form a larger oligomeric structure or
interact with each other. RDH11 has a very similar
property to retinoids to those of RDH12.
The described targeting strategy for the construction
of RDH12 and RDH15 knockout mice has several ad-
vantages compared to the more conventional method,
which requires screening of a mouse genomic library,
construction of restriction maps, mapping of exon/in-
tron boundaries and cloning of homologous fragments
into a vector. These steps are time consuming and re-
quire several months to complete. In our method, 50 and
30 arms are ampliﬁed by long range PCR and subse-
quently cloned in a basic targeting vector already con-
taining the necessary screening cassettes. This strategy
requires only weeks and is less dependent on the
availabilty of restriction sites, the only limitation being
that the 50 and 30 arms should not contain internal rec-
ognition sites for EcoR I (and/or Nhe I), Kpn I, and Not
I (or Hind III). This can be easily avoided by positioning
the 50 or 30 arms in regions of the gene of interest in
which these sites are not present.
For ampliﬁcation of the 50 and 30 arms, we used rTth
DNA polymerase, which might introduce mutations
into the ampliﬁed products due to replication errors.
This might reduce the eﬃciency of homologous recom-
bination. Depending on the construct, 3–5% of the cells
are found to be correctly targeted using the conventional
method. For RDH15 the targeting frequency was 1%.
However, the targeting frequency for RDH15 might
have been higher than observed, since correctly targeted
ES cell lines might have been missed due to our initial
screening procedure which was based on a PCR proto-
col. Genomic DNA isolated from ES cell lines cultured
on gelatin coated 96 wells plates, in our hands, appeared
to contain a compound which negatively aﬀects the ef-
ﬁciency of PCR ampliﬁcation.
In conclusion, a fast targeting strategy for the dis-
ruption of the genes was developed which enables us to
study physiological and pathological aspects of RDH12
and RDH15. Combining functional loss will help to
determine if these retinol dehydrogenases are responsi-
ble for the remaining 11-cis-retinol oxidation observed
in RDH5 knockout animals. It will furthermore shed
light on the possibility of retinol dehydrogenases being
involved in multigenic disorders.
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